drugset / Trial / NCT00292734
STILDEP: Zolpidem in Depressive and Dysthimic Patients
RandomizedFactorialOpen-labelTreatment
Summary
Primary objective: To show that the combination of Zolpidem + antidepressant therapy is more effective in the treatment of the secondary insomnia of depressive and dysthimic patients than antidepressant therapy alone in the acute phase of the disease.
Timeline
- Start
- 2005-01
- Primary completion
- —
- Completion
- 2006-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zolpidem | Small molecule | — | — |